Zhijun Xi
Shenyang Pharmaceutical University(CN)Peking University(CN)Office of Readiness and Response(US)Peking University First Hospital(CN)
Publications by Year
Research Areas
Autophagy in Disease and Therapy, Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Urological Disorders and Treatments, Renal cell carcinoma treatment
Most-Cited Works
- → PARP and RIP 1 are required for autophagy induced by 11'-deoxyverticillin A, which precedes caspase-dependent apoptosis(2011)129 cited
- → Kallikrein 4 is a Predominantly Nuclear Protein and Is Overexpressed in Prostate Cancer(2004)109 cited
- → Autophagy protects LNCaP cells under androgen deprivation conditions(2008)92 cited
- → Kallikrein 4 Is a Proliferative Factor that Is Overexpressed in Prostate Cancer(2007)91 cited
- → Akt inhibition attenuates rasfonin-induced autophagy and apoptosis through the glycolytic pathway in renal cancer cells(2015)63 cited
- → The PPARγ agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells(2014)55 cited